by Jaclyn Chasse, ND
This publication pulled together data from several studies, both mouse and human, to assess the role of trimethylamine-N-oxide (TMAO) on atherosclerosis. TMAO is a product of carnitine metabolism by microbiota in the gut.
by Tina Kaczor, ND, FABNO
This was an 8-week pilot study of daily yogic meditation versus relaxation in mildly depressed, elderly caregivers of dementia patients. The intervention group practiced Kundalini yoga with Kirtan Kriya meditation for 12 minutes daily; the placebo group listened to a prescribed relaxation CD for the same length of time. Measures of depression, mental health, cognitive function, and telomerase activity were assessed.
by Matthew J. Budoff, MD, FACC, FAHA
Cardiovascular disease is the leading cause of morbidity and mortality among the US population. Aged garlic extract helps to modulate multiple cardiovascular risk factors by lowering blood pressure, inhibiting platelet aggregation and adhesion, lowering cholesterol, and preventing LDL oxidation and smoking-induced oxidative damage.
by Jacob Schor, ND, FABNO
Telomere length is looking more and more like a possible predictor of health and longevity. The question this leaves all of us with is whether interventions that change telomere length will be associated with changes in either.
by Teresa M. Peterson
What began in 2004 as a student club at Southwest College of Naturopathic Medicine in Tempe, Ariz., has become a full-fledged network of community health projects around the globe. Naturopaths Without Borders (NWB) combines naturopathic healthcare and community-building to deliver education, sanitation, economic development, and health technology to underserved populations everywhere.
by Lise Alschuler, ND, FABNO
Systemically and over a lifespan, abnormal telomere shortening predicts risk for chronic diseases, namely cardiovascular disease and cancer. The opportunity to improve healthy longevity lies in preventing premature telomere shortening.
by Natural Medicine Journal
Mineral absorption and tolerability are significant concerns in clinical practice. In this interview, Jonathan Bortz, MD, uses the example of iron to illustrate the impact that the 6-stage chelate process can have on bioavailability.
